Cadence Pharmaceuticals Inc.
12481 High Bluff Drive
Suite 200
San Diego,
CA 92130
United States - Map
Phone: 858-436-1400
Fax: 858-436-1401
Web Site: http://www.cadencepharm.com
| Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on in-licensing, developing, and commercializing proprietary product candidates principally for use in the hospital setting in the United States and Canada. It has two Phase III product candidates in development, which include Acetavance, a proprietary intravenous formulation of acetaminophen for the treatment of acute pain and fever; and Omigard, an omiganan pentahydrochloride aqueous gel for the prevention of catheter-related infections. The company holds in-license rights to market Acetavance in Europe under the Perfalgan name and to commercialize Omigard for the prevention and treatment of device-related, surgical wound-related, and burn-related infections in North America and Europe. Cadence Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Cam L. Garner , 60
Co-Founder, Chairman and Chairman of Compensation Committee |
$
110.00K | N/A | Mr. Theodore R. Schroeder , 54
Co-Founder, Chief Exec. Officer, Pres |
$
610.00K |
$
0 | Mr. David Socks ,
Co-Founder and Sr. VP of Corp. Devel. & Strategy |
$
344.00K |
$
0 | Mr. William R. LaRue , 57
Chief Financial Officer, Principal Accounting Officer, Sr. VP, Treasurer and Assistant Sec. |
$
397.00K |
$
0 | Dr. James B. Breitmeyer M.D., Ph.D., 55
Chief Medical Officer and Exec. VP of Devel. |
$
478.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.22% Nasdaq 
Profile
